<?php
/**
 * MinMaxMuscle Forum - Pending thread creation: Petrelintide
 * Generated: 2026-11-03 (daily discovery run)
 * Instructions: Upload to blog.minmaxmuscle.com and run via SSH, OR apply
 *               directly via Asgaros Forum admin panel if REST endpoint is available.
 *
 * Usage:
 *   ssh user@blog.minmaxmuscle.com "php /tmp/20261103_petrelintide.php"
 *
 * Alternatively, if Asgaros REST endpoint available:
 *   POST /wp-json/asgaros-forum/v1/topics
 *   Authorization: Basic <base64(WP_USER:WP_APP_PASSWORD)>
 */

// WordPress bootstrap - adjust path if needed
define('ABSPATH', dirname(__FILE__) . '/');
require_once('/var/www/html/wp-load.php');

$topic_title   = 'New Research Thread: Petrelintide (ZP8396) — Zealand/Roche Amylin Analog for Obesity & T2DM';
$topic_content = <<<EOT
<p><strong>Compound overview:</strong> Petrelintide (ZP8396) is a once-weekly amylin analog developed by Zealand Pharma with Roche/Genentech. Two Phase 2 trials now complete. Phase 3 ZUPREME-3/4/5 program initiated (targeting ~7,000 participants).</p>

<p><strong>Key data points:</strong></p>
<ul>
  <li>ZUPREME-1 (non-diabetic obesity, N=493): up to 10.7% weight loss at 42 weeks vs. 1.7% placebo (Announced March 5, 2026)</li>
  <li>ZUPREME-2 (obesity + T2DM, N=220): up to 9.2% weight loss at 28 weeks, HbA1c reduced 0.61–0.88% vs. placebo (Announced October 7, 2026)</li>
  <li>Tolerability: GI discontinuation ~1.9% vs. ~1.7% placebo — nearly identical; no unexpected safety signals</li>
  <li>Combination trial with enicepatide (CT-388, Roche's GLP-1/GIP dual agonist) planned for H2 2026</li>
</ul>

<p><strong>Why this is interesting:</strong> The exceptional tolerability profile (placebo-equivalent GI side effects) makes petrelintide stand out from GLP-1 drugs. If the combination with CT-388 delivers additive weight loss, it could engage GLP-1 + GIP + amylin simultaneously — three separate satiety pathways.</p>

<p><strong>Discuss:</strong> Does petrelintide's tolerability profile justify its lower weight loss vs. GLP-1 drugs? Would you consider it for combination therapy? What does Phase 3 data need to show?</p>

<p><em>Research compounds discussed for educational purposes. Not FDA-approved for human use where applicable. Consult a healthcare provider before use.</em></p>
EOT;

// Asgaros Forum direct insert (adjust forum_id as needed — use forum ID for "Peptide Research" board)
global $wpdb;
$forum_id = 1; // Update to actual Peptide Research forum ID

$result = $wpdb->insert(
    $wpdb->prefix . 'asgarosforum_threads',
    [
        'title'      => $topic_title,
        'content'    => $topic_content,
        'forum_id'   => $forum_id,
        'author_id'  => 1,
        'date'       => current_time('mysql'),
        'approved'   => 1,
        'pinned'     => 0,
        'closed'     => 0,
    ]
);

if ($result) {
    $thread_id = $wpdb->insert_id;
    echo "Forum thread created: ID {$thread_id}\n";
    echo "Title: {$topic_title}\n";
    // Update D1 forum_topic_url: https://blog.minmaxmuscle.com/forum/topic/{$thread_id}/
} else {
    echo "Error creating thread: " . $wpdb->last_error . "\n";
}
